ODEFSEY 200 mg/1
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide · TABLET · Gilead Sciences, Inc.
Odefsey is a combination tablet taken by mouth that contains three medicines used to treat HIV infection. It belongs to a class of drugs called nucleoside analog reverse transcriptase inhibitors that work by slowing the reproduction of the virus in your body.
Key Facts
- Brand Name
- ODEFSEY
- Generic Name
- emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide
- NDC Code (Product)
61958-2101- Manufacturer
- Gilead Sciences, Inc.
- Strength
- 200 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA208351
- Drug Class
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 03/01/2016
Recall History
No Recall HistoryFrequently Asked Questions
What is ODEFSEY used for?
Odefsey is a combination tablet taken by mouth that contains three medicines used to treat HIV infection. It belongs to a class of drugs called nucleoside analog reverse transcriptase inhibitors that work by slowing the reproduction of the virus in your body.
Is ODEFSEY a controlled substance?
ODEFSEY is not classified as a controlled substance by the DEA.
What is the generic name for ODEFSEY?
The generic name for ODEFSEY is emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide. There are no other listed brand versions of emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide.
What is the NDC code for ODEFSEY 200 mg/1?
The NDC (National Drug Code) for ODEFSEY 200 mg/1 is 61958-2101, listed by Gilead Sciences, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)